Oct 1, 2024, 15:57
Measurable residual disease monitoring in AML
Top Biomedical Science shared on X:
“Measurable residual disease monitoring in AML:
Prospects for therapeutic decision-making and new drug development.”
Source: Top Biomedical Science/X
Authors: Nicholas J. Short, Richard Dillon
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 12, 2024, 12:43
Oct 12, 2024, 11:52
Oct 12, 2024, 11:42